Ultragenyx grants 17,567 RSUs to 11 new hires under inducement plan

Ultragenyx Pharmaceutical, Inc.

Ultragenyx Pharmaceutical, Inc.

RARE

0.00
  • Ultragenyx reported inducement equity awards totaling 17,567 restricted stock units to 11 newly hired non-executive officers, with a May 16, 2026 grant date.
  • The restricted stock units vest over four years, with 25% vesting on each anniversary of the grant date, subject to continued employment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605221630PRIMZONEFULLFEED9723226) on May 22, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.